HEDS is part of the School of Health and Related Research (ScHARR) at the University of Sheffield. We undertake research, teaching, training and consultancy on all aspects of health related decision science, with a particular emphasis on health economics, HTA and evidence synthesis.

Monday, 11 July 2011

Recent CUAs

Twice each month the CEA Registry Blog lists recently published cost utility studies and associated papers. 11 papers were listed this time. Here's a handful in our areas of our research interest:

Lazar LD, Pletcher MJ, Coxson PG, et al. Cost-Effectiveness of Statin Therapy for Primary Prevention in a Low-Cost Statin Era. Circulation. 2011 Jun 27. [Epub ahead of print] PubMed PMID: 21709063.

Delea TE, Tappenden P, Sofrygin O, et al. Cost-effectiveness of lapatinib plus capecitabine in women with HER2+ metastatic breast cancer who have received prior therapy with trastuzumab.  Eur J Health Econ. 2011 Jun 24. [Epub ahead of print] PubMed PMID: 21701940.

Hiligsmann M, Reginster JY. Cost Effectiveness of Denosumab Compared with Oral Bisphosphonates in the Treatment of Post-Menopausal Osteoporotic Women in Belgium. Pharmacoeconomics. 2011 Jun 21. [Epub ahead of print] PubMed PMID: 21692551.